7 reports

  • PIPELINE PRODUCTS - LATE-STAGE PIPELINE
  • Promising Drugs in Development for HCC

Phase II/ III Clinical Trials Status for HCC ##% ##% ##% ##% ##% ##% Completed Ongoing Terminated Planned Withdrawn Suspended Completed Trials by Drug Molecule Type ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##%

  • Clinical Trial
  • United States
  • World
  • Market Competition
  • MedImmune, LLC
  • CLINICAL TRIALS - LEADING INDUSTRY SPONSORS
  • Top Industry Sponsors of Clinical Trials in Seasonal Influenza

EnrollmentRate(Subjects/ Site/ Month) ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ## ## ## ## ## ## ## CLINICAL TRIALS - ENROLLMENT ANALYTICS Perspective Phase III seasonal influenza clinical trials reported higher patient enrollment, with an average

  • Clinical Trial
  • Influenza
  • United States
  • Market Competition
  • MedImmune, LLC

FIGURE ##: DIABETES DRUGS MARKET, GLOBAL, CLINICAL TRIAL SIZE BY STAGE OF ##. ##. ## Clinical Trial Size ##. ##. ##. ## Clinical Trial Size by Indication T##DM trials were consistently larger than T##DM trials, although clinical

  • Chronic Disease
  • Clinical Trial
  • Diabetes
  • Insulin
  • MedImmune, LLC

TS-## has shown efficacy in clinical trials both as a single agent as well as in combination with chemoradiotherapy regimens.

  • Chemotherapy
  • Clinical Trial
  • Therapy
  • Market Size
  • MedImmune, LLC
  • MEDI-551: CLINICAL TRIALS

SOME OF THE COMPANY' S OTHER CLINICAL-STAGE MOLECULES ARE BEING TESTED IN MORE THAN ONE CLINICAL TRIAL FOR MULTIPLE INDICATIONS.

  • Clinical Trial
  • Pharmaceutical
  • North America
  • United States
  • MedImmune, LLC
  • MEDI-551: CLINICAL TRIALS

t erm=P an k omab & ra nk =## Table ##. ## represents the clinical trials for PankoMab-GEX™.

  • Clinical Trial
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • MedImmune, LLC

IN ADDITION TO THE MARKETED YERVOY, THERE IS ONE DRUG IN PHASE III CLINICAL TRIALS FROM ASTRAZENECA.

  • Cancer Immunotherapy
  • Clinical Trial
  • Therapy
  • Demand
  • MedImmune, LLC